"Esophageal Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the ESOPHAGUS.
| Descriptor ID |
D004938
|
| MeSH Number(s) |
C04.588.274.476.205 C04.588.443.353 C06.301.371.205 C06.405.117.430 C06.405.249.205
|
| Concept/Terms |
Esophageal Neoplasms- Esophageal Neoplasms
- Esophageal Neoplasm
- Neoplasm, Esophageal
- Esophagus Neoplasm
- Esophagus Neoplasms
- Neoplasm, Esophagus
- Neoplasms, Esophagus
- Neoplasms, Esophageal
Cancer of Esophagus- Cancer of Esophagus
- Cancer of the Esophagus
- Esophagus Cancer
- Cancer, Esophagus
- Cancers, Esophagus
- Esophagus Cancers
- Esophageal Cancer
- Cancer, Esophageal
- Cancers, Esophageal
- Esophageal Cancers
|
Below are MeSH descriptors whose meaning is more general than "Esophageal Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Esophageal Neoplasms".
This graph shows the total number of publications written about "Esophageal Neoplasms" by people in this website by year, and whether "Esophageal Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 2 | 1 | 3 |
| 1998 | 1 | 0 | 1 |
| 1999 | 3 | 1 | 4 |
| 2000 | 3 | 1 | 4 |
| 2001 | 3 | 0 | 3 |
| 2002 | 2 | 0 | 2 |
| 2003 | 3 | 3 | 6 |
| 2004 | 2 | 2 | 4 |
| 2005 | 3 | 2 | 5 |
| 2006 | 1 | 1 | 2 |
| 2007 | 4 | 0 | 4 |
| 2008 | 0 | 3 | 3 |
| 2010 | 3 | 0 | 3 |
| 2011 | 5 | 2 | 7 |
| 2012 | 3 | 0 | 3 |
| 2013 | 6 | 0 | 6 |
| 2014 | 4 | 0 | 4 |
| 2015 | 4 | 0 | 4 |
| 2016 | 6 | 2 | 8 |
| 2017 | 4 | 1 | 5 |
| 2019 | 3 | 0 | 3 |
| 2020 | 2 | 0 | 2 |
| 2021 | 3 | 0 | 3 |
| 2022 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Esophageal Neoplasms" by people in Profiles.
-
Emerging Roles for Family Physicians in Diagnosing and Treating Barrett Esophagus. Am Fam Physician. 2022 Oct; 106(4):368-369.
-
Trastuzumab with trimodality treatment for oesophageal adenocarcinoma with HER2 overexpression (NRG Oncology/RTOG 1010): a multicentre, randomised, phase 3 trial. Lancet Oncol. 2022 02; 23(2):259-269.
-
Effect of endoscopic submucosal dissection on histologic diagnosis in Barrett's esophagus visible neoplasia. Gastrointest Endosc. 2022 Apr; 95(4):626-633.
-
Late cardiac toxicity of neo-adjuvant chemoradiation in esophageal cancer survivors: A prospective cross-sectional pilot study. Radiother Oncol. 2022 02; 167:72-77.
-
Validation of a DKK1 RNAscope chromogenic in situ hybridization assay for gastric and gastroesophageal junction adenocarcinoma tumors. Sci Rep. 2021 05 10; 11(1):9920.
-
Long-Term Quality of Life Following Endoscopic Therapy Compared to Esophagectomy for Neoplastic Barrett's Esophagus. Dig Dis Sci. 2021 05; 66(5):1580-1587.
-
Commentary: Don't fear the nonsteroidal anti-inflammatory drugs. J Thorac Cardiovasc Surg. 2021 02; 161(2):455-456.
-
A multicentre, phase IIa study of zolbetuximab as a single agent in patients with recurrent or refractory advanced adenocarcinoma of the stomach or lower oesophagus: the MONO study. Ann Oncol. 2019 09 01; 30(9):1487-1495.
-
Serum Levels of 25-Hydroxyvitamin D at Diagnosis Are Not Associated with Overall Survival in Esophageal Adenocarcinoma. Cancer Epidemiol Biomarkers Prev. 2019 08; 28(8):1379-1387.
-
Targeting glutamine-addiction and overcoming CDK4/6 inhibitor resistance in human esophageal squamous cell carcinoma. Nat Commun. 2019 03 21; 10(1):1296.